Delivery Order SPE2DB22D3501-SPE2DB24FTF18
- Not listed
- This is a $2,665.10 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4566997560 - Ropivacaine 0.2% 400 mg/200 mL 200 mL, with a performance period running through January 22, 2025. This delivery order is placed under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,633.30, is for the delivery of Ropivacaine 0.2% 400 mg/200 ml injections. The contract is a firm fixed-price, delivery order type with a completion date of February 25, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ropivacaine 0.2% 400 mg/200 ml medical products. The order has a firm fixed price of $1,749.64 and a completion date of January 28, 2025. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of 4557143835 - Ropivacaine 0.2% 400 mg/200 ml at a ceiling value of $1,297.38. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,713.56, is for the delivery of 4,566,581,858 units of 0.2% Ropivacaine 100 ML injectable medication. The contract has a firm fixed price pricing type and a completion date of December 3, 2024. Amerisourcebergen Drug Corp is a for-profit organization and a critical vendor for federal...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ropivacaine 0.5% 150 mg/30 ml solution. The contract has a firm fixed price of $4,437.96 and a completion date of November 22, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary vehicle for providing a broad...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,567.82, is for the delivery of 400 mg/200 mL vials of the anesthetic drug ropivacaine 0.2%. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL) in 200 mL units, with a contract ceiling value of $6,988.89. This is a firm fixed price delivery order with an ultimate completion date of October 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation, indicating competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL in 200 mL units) with a ceiling value of $20,075.28. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of November 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $21,044.99 firm fixed-price contract is for the supply of Ropivacaine 0.5% 150 mg/30 mL injectable drug. The contract has an ultimate completion date of August 20, 2024 and is not set aside for any particular business type. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FTF18Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,877.64, is for the delivery of 4562519583 ROPIVACAINE 0.2% 400 MG/200 ML 200ML medical supplies. The contract has a firm fixed price pricing type and an ultimate completion date of October 18, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 10/17/23 |